Biosimilars

COVID-19

Cataract Surgery

Cataract

Cataract Therapeutics

Clinical Diagnosis

Cornea

Dry Eye Awareness

Dry Eye

Gene Therapy

Geographic Atrophy

IOL Advances

Imaging

Glaucoma Awareness

Glaucoma Insights

Therapeutic Glaucoma

Interventional Glaucoma

Ocular Allergy

Ocular Surface Disease

Optic Relief

Optometry

Pediatrics

Pharmacy

Indispensable

Practice Management

Presbyopia

Ptosis

Refractive Surgery

Refractive

Retina

Surgery

Technology

Therapeutics

Understanding Antibiotic Resistance

Workplace

News

All News

Contributors

Money Matters

Media

Expert Interviews

Medical World News

Podcasts

Case Based Roundtable Series

Case of the Quarter

EyeView

Grand Rounds

Insights

Rapid Readout

Viewpoints

What’s Your WhEYE?

Conferences

Conference Coverage

Conference Listing

Events

Publications

Digital Edition

Europe Ophthalmology Times

Modern Retina

Supplements and Featured Publications

Partners

Subscribe

Resources

Job Board

About

Advertise

Privacy

Editorial

Terms and Conditions

Contact Us

Do Not Sell My Personal Information

Ophthalmology Times - Ophthalmology news, articles, and events

Facebook

Instagram

LinkedIn

Spotlight

Clinical

Glaucoma

Our disease focused Insights discussion feature Key Opinion Leaders (KOLs) and industry experts on topics that range from diagnosis and treatment to the patient journey, genetic testing and beyond.

1rem

Novel Drug Delivery Methods and Treatment Approaches for Retinal Diseases

Alice Epitropoulos, MD, and Laura M. Periman, MD, discuss comprehensive dry eye diagnosis.and management, covering key diagnostic tests, new therapies, and future advancements.

Bridging the Gap in Dry Eye Management with Targeted Interventions  

Judy Kim, MD and Peter Kaiser, MD present a comprehensive discussion on evolving therapeutic strategies for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), addressing barriers like step therapy, discuss the potential use of biosimilars, along with the efficacy and safety of newer therapies such as faricimab and high-dose aflibercept.

Changing Therapeutic Approaches in Neovascular AMD and DME

Promoting Early Detection and Timely Treatment of Diabetic Retinopathy and Diabetic Macular Edema

Retina specialists discuss 2-year data updates in the TENAYA, LUCERNE, YOSEMITE, and RHINE trials for wet macular degeneration (wet AMD) and diabetic macular edema (DME).

Longevity in Anti-VEGF Inhibitors Utilized in AMD/DME

Retina specialists, Carl D. Regillo, MD, FACS, FASRS, and Jennifer I. Lim, MD, FARVO, FASRS, provide key insights on biosimilars, overcoming barriers to biosimilar uptake, and the impact of biosimilars on retinal eye disorders.

Updates in the Use of Biosimilars in the Management of Retinal Eye Disorders

Intravitreal injection experts share methods of providing safe and effective Intravitreal injections.

Providing Safe and Effective Intravitreal injections

Experts discuss collaboration between ophthalmologists and optometrists in the management of patients with retinal eye disease.

Co-Management of Retinal Eye Disorders

Cynthia Matossian, MD, FACS, educates on the impact of dry eye flares on eyesight, as well as treatment therapies.

Defining Flares in Dry Eye Disease